Related references
Note: Only part of the references are listed.Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations
Gregory M. Laird et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Kai Deng et al.
NATURE (2015)
Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression
Uri R. Mbonye et al.
PROTEOMICS (2015)
Visualization of Positive Transcription Elongation Factor b (P-TEFb) Activation in Living Cells
Koh Fujinaga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
Sujatha Venataraman et al.
Oncotarget (2015)
Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling
Guochun Jiang et al.
AIDS (2014)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
Release of Positive Transcription Elongation Factor b(P-TEFb)from 7SK Small Nuclear Ribonucleoprotein ( snRNP) Activates Hexamethylene Bisacetamide- inducible Protein ( HEXIM1) Transcription*
Pingyang Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C. Korin Bullen et al.
NATURE MEDICINE (2014)
HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters
Sebastian Eilebrecht et al.
NUCLEIC ACIDS RESEARCH (2014)
Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
Z. Zou et al.
ONCOGENE (2014)
Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR
Celina M. Abreu et al.
PLOS ONE (2014)
Marine natural products: Bryostatins in preclinical and clinical studies
Peter Kollar et al.
PHARMACEUTICAL BIOLOGY (2014)
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy
Anthony R. Cillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli et al.
SCIENCE (2014)
Screening for noise in gene expression identifies drug synergies
Roy D. Dar et al.
SCIENCE (2014)
Reactivation of latent HIV-1 by new semi-synthetic ingenol esters
Diego Pandelo Jose et al.
VIROLOGY (2014)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya-Chi Ho et al.
CELL (2013)
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Daniela Boehm et al.
CELL CYCLE (2013)
Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV Transcription
Koen Bartholomeeusen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
Anna C. Belkina et al.
JOURNAL OF IMMUNOLOGY (2013)
Cyclin T1 and CDK9 T-Loop Phosphorylation Are Downregulated during Establishment of HIV-1 Latency in Primary Resting Memory CD4+ T Cells
Sona Budhiraja et al.
JOURNAL OF VIROLOGY (2013)
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
Zichong Li et al.
NUCLEIC ACIDS RESEARCH (2013)
CTIP2 is a negative regulator of P-TEFb
Thomas Cherrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HIV-1 transcription and latency: an update
Carine Van Lint et al.
RETROVIROLOGY (2013)
Transcription Factors Mediate the Enzymatic Disassembly of Promoter-Bound 7SK snRNP to Locally Recruit P-TEFb for Transcription Elongation
Ryan P. McNamara et al.
CELL REPORTS (2013)
An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+T Cells from Aviremic Patients
Celsa A. Spina et al.
PLOS PATHOGENS (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
Mark Lebwohl et al.
JAMA DERMATOLOGY (2013)
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Sophie Bouchat et al.
AIDS (2012)
Small-Molecule Inhibition of BRDT for Male Contraception
Martin M. Matzuk et al.
CELL (2012)
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study
Robert J. Morgan et al.
INVESTIGATIONAL NEW DRUGS (2012)
Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein
Koen Bartholomeeusen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Camellia Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells
Emily S. Wires et al.
JOURNAL OF NEUROVIROLOGY (2012)
Regulation of Cyclin T1 and HIV-1 Replication by MicroRNAs in Resting CD4+ T Lymphocytes
Karen Chiang et al.
JOURNAL OF VIROLOGY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
PKC phosphorylates HEXIM1 and regulates P-TEFb activity
Koh Fujinaga et al.
NUCLEIC ACIDS RESEARCH (2012)
MicroRNA-Mediated Restriction of HIV-1 in Resting CD4+ T Cells and Monocytes
Karen Chiang et al.
VIRUSES-BASEL (2012)
Reactivation of Latent HIV-1 by Inhibition of BRD4
Jian Zhu et al.
CELL REPORTS (2012)
Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression
Jonathan Karn et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs
Lisa N. McKernan et al.
ADVANCES IN VIROLOGY (2012)
HIV-1 Replication and Latency Are Regulated by Translational Control of Cyclin T1
Mainul Hoque et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Moises Perez et al.
CURRENT HIV RESEARCH (2010)
HIV-1 Tat Assembles a Multifunctional Transcription Elongation Complex and Stably Associates with the 7SK snRNP
Bijan Sobhian et al.
MOLECULAR CELL (2010)
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
Rajeev Mehla et al.
PLOS ONE (2010)
Host hindrance to HIV-1 replication in monocytes and macrophages
Anna Bergamaschi et al.
RETROVIROLOGY (2010)
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors
Anna C. Pavlick et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area (ANRS CO 01)
Veronique Avettand-Fenol et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
Sophie Reuse et al.
PLOS ONE (2009)
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
Laurence Colin et al.
RETROVIROLOGY (2009)
Identification of host proteins required for HIV infection through a functional genomic screen
Abraham L. Brass et al.
SCIENCE (2008)
A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code
Miriam Calao et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription
Xavier Contreras et al.
PLOS PATHOGENS (2007)
Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells
Tzu-Ling Sung et al.
RETROVIROLOGY (2006)
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
C Smit et al.
AIDS (2006)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue
A Biancotto et al.
JOURNAL OF VIROLOGY (2004)
Combination antiretroviral therapy and the risk of myocardial infarction
N Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection
S Crowe et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate
S Bocklandt et al.
ANTIVIRAL RESEARCH (2003)
HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class 1
O Kutsch et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2002)
Effects of prostratin on T-cell activation and human immunodeficiency virus latency
YD Korin et al.
JOURNAL OF VIROLOGY (2002)
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
J Kulkosky et al.
BLOOD (2001)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
TW Chun et al.
NATURE MEDICINE (2000)